1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. POLYPID LTD
Polypid Ltd
XNAS: PYPD
Download real time
5.200.03(0.58%)
69.93% Gain from 52W Low
5,405.1
XNAS Volume

XNAS 22 Sep, 2026 11:00 AM (EDT)

Portfolio

Alert

My Notes

Board Meeting
The next board meeting for Polypid Ltd is on 29 Sep 2026 for the purpose of Lytham Partners Fall 2026 Investor ConferenceSee details

Polypid Ltd quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Polypid Ltd quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
  • NEUTRAL

    Quarterly Revenue Polypid Ltd Jun-2026 Quarterly Revenue is $0 Million which is growth of 0% YoY.

  • POSITIVE

    Quarterly Net Profit Polypid Ltd Jun-2026 Quarterly Net Profit is $-8 Million which is growth of 21.3% YoY.

Polypid Ltd, Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphJun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23
Operating Rev.
Cost Of Rev.
-------------
Gross Profit
-------------
⌄
7.97.88.57.59.47.68.27.46.16.365.35.8
Operating Profit
-7.9-7.8-8.5-7.5-9.4-7.6-8.2-7.4-6.1-6.3-6-5.3-5.8
⌄
000.30-0.5-0.7-0.3-0.4-0.2-0.1-0.6-0.3-0
Profit Before Tax
-7.8-7.7-8.6-7.4-9.9-8.3-8.5-7.7-6.3-6.4-6.4-5.6-5.8
Tax
0-0.100.10000000
⌄
-7.9-7.7-8.5-7.5-10-8.3-8.5-7.8-6.3-6.5-6.4-5.6-5.8
Diluted NI Avail to Com Stockholders Ann.
-7.9-7.7-8.5-7.5-10-8.3-8.5-7.8-6.3-6.5-6.4-5.6-5.8
Basic EPS
-0.4-0.4-0.4-0.4-0.8-0.7-1.1-1.2-1.3-1.4-3.8-3.4-3.9
Diluted EPS After ExtraOrdinary
-0.4-0.4-0.4-0.4-0.8-0.7-1.1-1.2-1.3-1.4-4-3.4-3.9
Number Of Shares End
22.621.920.720.112.811.87.66.454.71.81.71.5
Net Income Continuing Discontinued Operations
-7.9-7.7-8.5-7.5-10-8.3-8.5-7.8-6.3-6.5-6.4-5.6-5.8
Normalized Income
-7.9-7.7-8.2-7.5-10-8.3-8.5-7.8-6.3-6.5-6.4-5.6-5.8
Interest Income
0------------
Interest
--0-0.50.70.30.40.2-10.30
Net Interest Income
000.30-0.5-0.7-0.3-0.4-0.2-0.1-0.6-0.3-0
EBIT
-7.9-7.8-8.9-7.5-9.4-7.6-8.2-7.4-6.1-6.3-5.3-5.3-5.8
EBITDA
-7.9-7.8-8.9-7.5-9.4-7.6-8.2-7.4-6.1-6.3-5.3-5.3-5.8
Reconciled Cost Of Rev.
-------------
Reconciled Depr.
-------------
Profit From Continuing Operations
-------------
Normalized EBITDA
-7.9-7.8-8.5-7.5-9.4-7.6-8.2-7.4-6.1-6.3-5.3-5.3-5.8
*All financials are in USD Million and price data in USD
Add metric to table
Search...

Polypid Ltd competitor comparison and performance snapshot within industry

Polypid Ltd annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEUTRAL

    Annual Revenue Polypid Ltd Annual Revenue is $0 Million which is growth of 0% YoY.

  • NEGATIVE

    Annual Net Profit Polypid Ltd Annual Net Profit is $-34 Million which is growth of -17.7% YoY.

Polypid Ltd, Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '13
⌄
-
-
 
Cost Of Rev. Ann.
-
-
 ----------
Gross Profit Ann.
-
-
 ----------
Operating Exp. Ann.
-5.3%
4.6%
31.6332822.938.943.126.318.618.413.810.33.6
Operating Profit Ann.
-
-
-31.6-33-28-22.9-38.9-43.1-26.3-18.6-18.4-13.8-10.3-3.6
⌄
-
-
0.4-0.4-1-1.2-1.10.50.500.1-40.7-1.1
Other Exp. Ann.
-
-
 -0.8-0.20.50-11.111.624.2---0.3
PBT Ann.
-
-
-31.6-34.2-29-23.8-39.4-42.6-36.9-6.95.9-54.5-11.4-3.9
Tax Ann.
-
-
-0.100.10.1-------
⌄
-
-
-31.5-34.2-29-23.9-39.6-42.6-42.9-13.30.1-55.7-11.4-4.7
Diluted NI Avail to Com Stockholders Ann.
-
-
-31.5-34.2-29-23.9-39.6-42.6-42.9-13.3-0.5-55.7-11.4-4.7
EPS Ann.
-
-
 -2.1-4.9-17-61.2-68.4-134.4-33.90.2-189.6-38.7-23.8
Diluted EPS Ann.
-
-
 -2.1-4.9-17-61.2-68.4-134.4-33.9-1.2-189.6-38.7-23.8
Number Of Shares End
209.2%
103%
 20.77.61.80.70.60.60.4---0.3
Total Exp. Ann.
-5.3%
4.6%
 332822.938.943.126.318.618.413.810.33.6
Net Income Continuing Discontinued Operations Ann.
-
-
-31.5-34.2-29-23.9-39.6-42.6-36.9-6.95.9-54.5-11.4-3.9
Normalized Income Ann.
-
-
-31.2-33.3-29-24.1-40-42.7-25.7-18.5-18.3-54.5-11.4-3.6
Interest Income Ann.
18.6%
0%
 0.5-0.60.30.50.50.10.1---
Interest Ann.
-3.5%
-
 0.911.61-------
EBITDA Ann.
-
-
-31.9-31.8-26.4-20.4-36.7-42-25.3-17.6-18-13.6-10.1-3.5
Reconciled Cost Of Rev. Ann.
-
-
 ----------
Reconciled Depr. Ann.
-4.1%
8.4%
 1.51.61.81.71.1110.40.20.10.1
Profit From Continuing Operations Ann.
-
-
 -34.2-29-23.9-39.6-42.6-36.9-6.95.9-54.5-11.4-3.9
Normalized EBITDA Ann.
-
-
-31.6-31-26.4-20.6-37.2-42.1-14.1-29.2-42.2-13.6-10.1-3.2
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Operating Exp. Ann.
1Y CHG
17.9%
2Y CAGR
20%
3Y CAGR
-5.3%
5Y CAGR
4.6%
7Y CAGR
8.7%
Operating Expenses Annual Cr growth is higher than historical averages.

Polypid Ltd balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Total Shareholders Fund Polypid Ltd Dec-2025 Total Shareholders Fund is $11 Million which is growth of 42.8% YoY.

  • NEGATIVE

    Total Assets Polypid Ltd Dec-2025 Total Assets is $22 Million which is growth of -11.6% YoY.

Polypid Ltd, Balance Sheet, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '13
⌄
-5%
-21.7%
22.325.215.42644.275.933.814.52319.22
⌄
-17.5%
29.5%
11.317.517.520.18.33.12.896.2111.653.21
⌄
23.8%
-31.5%
117.7-2.15.83672.830.9-81.7-88.7-341
Total Capitalization Ann.
-6.4%
-31.5%
118.34.313.43672.830.9-81.7-88.7-341
Tangible Assets Ann.
23.8%
-31.5%
117.7-2.15.83672.830.9-81.7-88.7-341
Working Capital Ann.
10.2%
-29.9%
7.53.9-1.25.626.744.324.84.315.416.61.1
Invested Capital Ann.
-11.6%
-30.3%
1215.18.317.43672.830.9-81.7-88.7-341
Tangible Book Value Ann.
23.8%
-31.5%
117.7-2.15.83672.830.9-81.7-88.7-341
Borrowings Ann.
-41.1%
-
2.89.611.813.7-------
Net Debt Ann.
-
-
--5.13.1-------
Share Issued Ann.
196.2%
97.9%
18.210.21.70.70.60.60.60.40.40.40.3
Number Of Shares End
209.2%
103%
20.77.61.80.70.60.60.4---0.3
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Assets Ann.
1Y CHG
-11.5%
2Y CAGR
20.3%
3Y CAGR
-5%
5Y CAGR
-21.7%
7Y CAGR
6.3%
Total Assets Annual is falling faster than historical averages.
Total Current Liabilities Ann.
1Y CHG
-39.4%
2Y CAGR
2.7%
3Y CAGR
-3.6%
5Y CAGR
21.6%
7Y CAGR
11%
Total Current Liabilities Annual Cr is falling faster than historical averages.
Total ShareHolders Funds Ann.
1Y CHG
42.9%
3Y CAGR
23.8%
5Y CAGR
-31.5%
Total ShareHolders Funds Annual growth is stable compared to historical averages.

Polypid Ltd ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Book Value Per Share Polypid Ltd Book Value Per Share is $0 which is growth of -64.8% YoY.

  • NEUTRAL

    ROE Polypid Ltd ROE is 0% which is growth of 0% YoY.

Polypid Ltd, Ratios, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '13
RoA Ann. %
-
-
--142.99%-115.45%-112.69%-70.95%-78.31%-55.24%0.48%-264.05%-59.22%-265.15%
ROE Ann. %
-
-
--1,038.73%-1,278.60%-189.32%-78.36%-82.76%-----
ROIC %
-
-
--56.3-44.4-30.9-32.1-15.1-33.2----
OPM Ann. %
-
-
-----------
Inventory Turnover Ratio Ann.
-
-
-----------
Asset Turnover Ann. %
-
-
-----------
Working Capital Turnover Ann.
-
-
Quick Ratio Ann.
-
-
-1.20.71.5415.510.325.410.52.9
Current Ratio Ann.
-
-
-1.30.81.74.316.410.62.25.610.83.2
Interest Coverage Ratio Ann.
-
-
--29.5-13.7-37.5-------
LT Debt To Equity Ann.
-
-
-0.3-1.5-------
*All financials are in USD Million and price data in USD
Add metric to table
Search...

Polypid Ltd cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Cash From Operating Activity Polypid Ltd Cash From Operating Activity is $-28 Million which is growth of -26.9% YoY.

  • NEGATIVE

    Net Cash Flow Polypid Ltd Net Cash Flow is $-9 Million which is growth of -191.0% YoY.

Polypid Ltd, Cash Flow, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '13
⌄
-
-
-27.9-22-17.2-34.3-32.4-21.6-17.4-16.7-12.3-9.7-2.5
⌄
-
-
-6.7-0.33.816.636.9-40.8-23.611-8.4-8.1-0.1
⌄
15.7%
-16.6%
25.432.41016.4162.837.79.414.426.32.9
Cash Plus Cash Eqv. End Of Year Ann.
-10.2%
6.1%
6.615.85.79.110.54.94.57.83.910.21.3
Net Increase In Cash Plus Cash Eqv.s Ann.
-
-
-9.210.1-3.5-1.35.60.4-3.33.7-6.38.50.3
Cash Plus Cash Eqv. Begin Of Year Ann.
14.6%
28.6%
15.85.79.110.54.94.57.84.110.21.71
Income Tax Paid Supplemental Data Ann.
-
-
000-------
Interest Paid Supplemental Data Ann.
-5%
-
0.6110.7-------
Capex Ann.
-
-
-0.2-0.1-0.2-1.8-3-1.2-0.9-3.1-1.9-0.5-0.1
Issuance Of Capital Stock Ann.
94.9%
-12.3%
32.635.98.74.462.837.79.414.326.32.9
Issuance Of Debt Ann.
-
-
-11.7-------
Repayment Of Debt Ann.
-
-
-6.4-3.3-2.6-0.4-------
Repurchase Of Capital Stock Ann.
-
-
-----------
Free Cash Flow Ann.
-
-
-28.1-22-17.4-36.1-35.4-22.8-18.2-19.8-14.2-10.3-2.6
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Cash from Financing Act. Ann.
1Y CHG
-21.6%
2Y CAGR
59.4%
3Y CAGR
15.7%
5Y CAGR
-16.6%
7Y CAGR
15.3%
Cash from Financing Annual Activity is falling faster than historical averages.
×